| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | -273.00K | -617.00 |
| Net Income | ― | -248.00 | -124.00 | -273.00K | -806.00 |
Balance Sheet | |||||
| Total Assets | 190.84K | 162.22K | 355.13K | 570.45K | 832.82K |
| Cash, Cash Equivalents and Short-Term Investments | 163.95K | 150.13K | 344.58K | 555.13K | 826.47K |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 39.02K | 55.61K | 69.96K | 191.75K | 181.41K |
| Stockholders Equity | 151.81K | 106.60K | 285.17K | 378.70K | 651.41K |
Cash Flow | |||||
| Free Cash Flow | -252.00 | -264.53K | -279.00 | -271.35K | -506.00 |
| Operating Cash Flow | -252.00 | -264.53K | -279.00 | -271.35K | -506.00 |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 180.00 | 70.09K | 0.00 | 0.00 | 1.92K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
51 Neutral | £44.00M | -5.12 | 159.67% | ― | ― | -36.54% | |
50 Neutral | £2.08M | -3.41 | ― | ― | ― | ― | |
44 Neutral | £1.48M | -4.33 | ― | ― | ― | ― | |
42 Neutral | £1.10M | ― | ― | ― | ― | ― | |
39 Underperform | £1.08M | -1.18 | 68.75% | ― | ― | -61.11% |
Beacon Rise Holdings PLC has secured further advanced subscription agreements with new and existing investors to raise approximately £150,000 in gross proceeds, bringing total advanced subscription funds raised to about £350,000 pending completion. The net proceeds are earmarked to cover part of the transaction fees linked to its proposed acquisitions and planned market admission, as well as to bolster working capital, underscoring continued investor support and providing additional financial runway as the company moves toward completing its acquisition and listing objectives.
Under the terms of the advanced subscription agreements, investors will receive new ordinary shares at a 10% discount to the issue price in any equity fundraising that coincides with admission, or at a fixed £1.80 per share if admission has not occurred by 28 August 2026. Some of these agreements are structured to qualify under the UK Enterprise Investment Scheme, which may enhance their attractiveness to investors and support Beacon Rise’s efforts to fund its strategic transactions and strengthen its position ahead of a potential listing.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC reported that all resolutions were approved at its general meeting, allowing a planned share capital reorganisation to proceed. The move is designed to alter only the nominal value structure of the share capital without changing the number of ordinary shares held by existing shareholders, leaving economic rights and identifiers of the stock unchanged.
Following the vote, 1,550,333 new ordinary shares and an equal number of new deferred shares will be created, with the new ordinary shares expected to begin trading on the London Stock Exchange’s Main Market on 13 March 2026. The reorganisation formalises the company’s capital structure while preserving shareholder positions, signalling an administrative adjustment rather than a dilution or change in control for investors.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has entered into a new advanced subscription agreement with a fresh investor to raise approximately £50,000, providing additional funds to support fees tied to its proposed acquisitions and planned admission to trading, as well as general working capital. Under the agreement, the investor will receive new ordinary shares at a 10% discount to the issue price of any equity raise conducted alongside admission, or at a fixed price if admission does not occur by 28 August 2026, highlighting the company’s continued reliance on pre‑admission financing to advance its acquisition strategy and meet near‑term obligations.
The issuance of the new ordinary shares remains conditional on Beacon Rise obtaining the necessary shareholder authorities to issue the securities, and the company has signalled that further updates will be provided in due course. This incremental capital strengthens Beacon Rise’s ability to shoulder transaction costs and maintain operational momentum as it works toward completing its acquisitions and securing its listing, with the pricing structure of the agreement balancing investor incentive against execution risk on the admission timeline.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has called a general meeting for 12 March 2026 to seek shareholder approval for a share capital reorganisation and updated corporate authorities. The proposals include subdividing each existing £1.00 ordinary share into a low-nominal-value ordinary share and a largely valueless deferred share, without changing shareholders’ overall holdings or rights, aside from the nominal value adjustment.
If approved, the new ordinary shares will be admitted to trading on the London Stock Exchange’s main market on 13 March 2026, maintaining the same ISIN and SEDOL. The company is also asking investors to authorise directors to issue new equity, including on a non-pre-emptive basis, adopt new articles of association, extend the deadline to complete its initial transaction by 12 months to March 2027, and permit shorter notice periods for non-annual general meetings, collectively enhancing its flexibility to execute future transactions and capital raisings.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has abandoned its planned £0.5 million acquisition of Lyfe Health Isle of Wight Limited, which trades as Cowes Chiropractic, after concluding from commercial and financial due diligence that the deal would not be in shareholders’ best interests. Despite terminating this transaction, the company continues due diligence on three other previously announced targets – Ergotec, a separate chiropractic business and a training provider – all of which are classified as initial transactions under UK listing rules and have led to the ongoing suspension of Beacon Rise’s shares from the FCA’s Official List and trading on the London Stock Exchange’s Main Market. The company emphasised that these proposed deals are independent of each other and not inter-conditional, and it plans to proceed with cancellation of its current listing and admission in conjunction with binding agreements on at least one acquisition, while noting there is no certainty any transaction will complete and that trading in its shares would resume if all proposed acquisitions were to fail, subject to regulatory approval.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC, listed on the London Stock Exchange under ticker BRS, has an issued share capital of 1,550,333 ordinary shares of £1.00 each, all carrying one vote per share and with no shares held in treasury. This clarification of the company’s total voting rights provides a definitive share count for investors and is intended to assist shareholders in determining whether they must notify holdings or changes in holdings under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, reinforcing transparency around the company’s ownership structure.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has completed the issuance of 138,851 new ordinary shares at £1.60 each, finalising a £0.22 million investment made in October 2025 via advanced subscription agreements ahead of the implementation of the UK’s new Public Offers and Admissions to Trading Regulations 2024. The new shares, issued on a non-pre-emptive basis under existing shareholder authorities and expected to be admitted to trading around 19 January 2026, increase the company’s total voting share capital to 1,550,333 shares and slightly alter the ownership structure, with director and major shareholder Xiaobing Wang now holding 54.18% of the enlarged share capital, information that investors can use to assess disclosure thresholds and control dynamics within the company.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has entered into an advanced subscription agreement with a new investor to raise approximately £150,000 in gross proceeds. The funds will be used to help cover transaction fees related to its proposed acquisitions, its planned admission to market, and to support working capital needs, with the new shares to be issued at a discount to any contemporaneous equity raise and on terms structured to qualify under the UK Enterprise Investment Scheme, subject to shareholder authorities and further updates from the company.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £159.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC, listed on the London Stock Exchange under ticker BRS, has updated its registered office address to Room 639, 6th Floor, 2 Kingdom Street, London, W2 6BD. The administrative change in corporate domicile location is not expected to affect the company’s day-to-day operations but formally updates its official point of contact and may have minor implications for corporate governance and regulatory correspondence.
The most recent analyst rating on (GB:BRS) stock is a Hold with a £160.00 price target. To see the full list of analyst forecasts on Beacon Rise Holdings PLC stock, see the GB:BRS Stock Forecast page.
Beacon Rise Holdings PLC has appointed chartered accountant Mark Wrenford Tavener to its board as Chief Financial Officer, effective 1 January 2026, after he joined the company as a non-board CFO in August 2025. The board expects Tavener’s extensive audit, corporate finance and listed-company CFO experience to strengthen Beacon Rise’s financial oversight, support accurate reporting and help drive the company’s long-term strategic and growth objectives as it develops its operations.